News about our Companies - MedTech Innovator

Respira wins NIH grant

DateSep 25 2021

Today, we were notified that Respira Labs was chosen out of 103 applicants in the US (three winners, only female and Latino led) to be awarded The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases.

Is India geared up for regular screening of CHDs in kids?

DateSep 25 2021

HD Medical has developed the HD Steth, cleared by the US FDA, that addresses this problem.

21 start-ups selected to innovate for healthy ageing, feat. SepTec

DateSep 22 2021

The awards are part of the Healthy Longevity Global Competition – a multiyear, multimillion-dollar international competition seeking breakthrough innovations to extend human health and function later in life.

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health

DateSep 21 2021

Xealth, the leader in enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health.

Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25

DateSep 21 2021

Along with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.

Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure

DateSep 20 2021

The new code is C9780, Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance.

Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor

DateSep 16 2021

Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS).

FDA Clears Fully Automated Cardiac Ultrasound Solution to Measure 2D and Doppler

DateSep 14 2021

Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography.